Cargando…
Postoperative Circulating Tumor DNA Can Predict High Risk Patients with Colorectal Cancer Based on Next-Generation Sequencing
SIMPLE SUMMARY: Circulating tumor DNA (ctDNA) is a minimally invasive biomarker useful for monitoring minimum residual disease, recurrence, and treatment response in colorectal cancer (CRC). We analyzed circulating tumor DNA from patients with CRC to evaluate analytical and clinical performances usi...
Autores principales: | Lee, Chul Seung, Kim, Hoon Seok, Schageman, Jeoffrey, Lee, In Kyu, Kim, Myungshin, Kim, Yonggoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391973/ https://www.ncbi.nlm.nih.gov/pubmed/34439344 http://dx.doi.org/10.3390/cancers13164190 |
Ejemplares similares
-
Targeted Next-Generation Sequencing of Plasma Cell-Free DNA in Korean Patients with Hepatocellular Carcinoma
por: Chae, Hyojin, et al.
Publicado: (2021) -
Prognostic value of measurable residual disease monitoring by next-generation sequencing before and after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
por: Kim, Hee-Je, et al.
Publicado: (2021) -
Simultaneous Monitoring of Mutation and Chimerism Using Next-Generation Sequencing in Myelodysplastic Syndrome
por: Lee, Jong-Mi, et al.
Publicado: (2019) -
Impact of Integrated Genetic Information on Diagnosis and Prognostication for Myeloproliferative Neoplasms in the Next-Generation Sequencing Era
por: Lee, Jong-Mi, et al.
Publicado: (2021) -
Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome
por: Yoo, Jaeeun, et al.
Publicado: (2020)